| Record ID | marc_columbia/Columbia-extract-20221130-014.mrc:129390236:4416 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-014.mrc:129390236:4416?format=raw |
LEADER: 04416cam a22003374a 4500
001 6915877
005 20221130191529.0
008 070713s2008 nyua b 001 0 eng d
020 $a9781588299482
020 $a1588299481
035 $a(OCoLC)ocn166358009
035 $a(OCoLC)166358009
035 $a(NNC)6915877
035 $a6915877
040 $aBTCTA$cBTCTA$dBAKER$dYDXCP$dCDX$dNNC-M$dOrLoB-B
050 4 $aRC270.8$b.E34 2008
082 04 $a616.99406$222
245 00 $aEgfr signaling networks in cancer therapy /$cedited by John D. Haley, William John Gullick.
260 $aNew York :$bHuman Press,$c2008.
300 $axi, 393 pages :$billustrations (some color) ;$c27 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gSect. I.$tEGFR Signaling Networks -- $g1.$tEGF receptor Family Extracellular Domain Structures and Functions /$rAntony W. Burgess and Thomas P. J. Garrett -- $g2.$tEGF Family Heterodimers Cancer Pathogenesis /$rHoward M. Stern -- $g3.$tStructure-function of EGFR Kinase Domain and Its Inhibitors /$rCharles Eigenbrot -- $g4.$tInternalization and Degradation of EGF receptor /$rAlexander Sorkin -- $g5.$tDifferential Dependence of EGFR and ErbB2 on the Molecular Chaperone Hsp90 /$rWanping Xu and Len Neckers -- $g6.$tActivation of STATs 3 and 5 through the EGFR Signaling Axis /$rPriya Koppikar and Jennifer Rubin Grandis -- $g7.$tThe intersection of EGFR and Ras Signaling Rathways /$rMarie Wislez and Jonathan M. Kurie -- $g8.$tPhosphoinositide 3-Kinase Enzymes as Downstream Targets of the EGF Receptor /$rJan Domin -- $g9.$tConvergence of EGF Receptor and Src Family Signaling Networks in Cancer /$rJessica E. Pritchard, Allison B. Jablonski and Sarah J. Parsons -- $g10.$tMolecular Crosstalk between E-cadherin and EGFR Signaling Networks /$rJulie Gavard and J. Silvio Gutkind -- $g11.$tCrosstalk Between Insulin-like Growth Factor (IGF) and Epidermal Growth Ractor (EGF) Receptors /$rMarc A. Becker and Douglas Yee -- $g12.$tNegative Regulation of Signaling by the EGFR Family /$rKermit L. Carraway III, Lily Yen, Ellen Ingalla and Colleen Sweeney -- $g13.$tNuclear ErbB Receptors: Pathways and Functions /$rHong-Jun Liao and Graham Carpenter -- $g14.$tTemporal Dynamics of EGF Receptor Signaling by Quantitative Proteomics /$rBlagoy Blagoev, Irina Kratchmarova, Jesper V. Olsen and Mathias Mann -- $g15.$tComputational and Mathematical Modeling of the EGF Receptor System /$rColin G. Johnson, Emmet McIntyre and William Gullick -- $gSect. II.$tEGFR in Tumorigenesis and EGFR Tyrosine Kinase Inhibitors in Cancer Therapy -- $g16.$tExpression and Prognostic Ssignificance of EGFR in Solid Tumors /$rNicola Normanno, Caterina Bianco, Antonella De Luca, Luigi Strizzi, Marianna Gallo, Mario Mancino and David S. Salomon -- $g17.$tSignalling by EGF Receptor in Human Cancers: Accentuate the Positive, Eliminate the Negative /$rHaley L. Bennett, Tilman Brummer, Paul Timpson, Kate I. Patterson and Roger J. Daly -- $g18.$tEGFR Signaling in Invasion, Angiogenesis AND Metastasis /$rCarol Box, Joanna Peak, Susanne Rogers and Suzanne Eccles -- $g19.$tConstitutive Activation of Ttruncated EGF Receptors in Glioblastoma /$rCarol J. Wikstrand and Darell D. Bigner -- $g20.$tEGFR Mutations, Other Molecular Alterations Related To Sensitivity to EGFR Inhibitors, and Molecular Testing for EGFR-Targeted Therapies in Non-Small Cell Lung Cancer /$rDavid A. Eberhard -- $g21.$tCrosstalk Between COX-2 and EGFR: A Potential Therapeutic Opportunity /$rAndrew J. Dannenberg and Kotha Subbaramaiah -- $g22.$tCellular Sensitivity to EGF Receptor Inhibitors /$rStuart Thomson, John D. Haley and Robert Yauch -- $g23.$tUtilizing Combinations of Molecular Targeted Agents to Sensitize Tumor Cells to EGFR Inhibitors /$rElizabeth Buck, Alexandra Eyzaguirre and Kenneth K. Iwata.
650 0 $aCancer$xTreatment.$0http://id.loc.gov/authorities/subjects/sh85019547
650 0 $aCancer$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh85019497
650 12 $aNeoplasms, Second Primary.$0https://id.nlm.nih.gov/mesh/D016609
650 22 $aDrug Therapy.$0https://id.nlm.nih.gov/mesh/D004358
700 1 $aHaley, John D.$0http://id.loc.gov/authorities/names/no2008180938
700 1 $aGullick, William John.$0http://id.loc.gov/authorities/names/no2008180944
852 00 $boff,hsl$hRC270.8$i.E34 2008